PRIMARY DOCUMENT

Company

Cyclerion Therapeutics, Inc.

Filed

June 17, 2019

Accession Number

0001654954-19-007382

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →